Aim & Scope
Current Drug Targets aims to cover the latest and most outstanding developments on the medicinal chemistry and pharmacology of molecular drug targets e.g. disease specific proteins, receptors, enzymes, genes. Current Drug Targets publishes guest edited thematic issues written by leaders in the field covering a range of current topics of drug targets. The journal also accepts for publication full-length/mini review articles and drug clinical trial studies. As the discovery, identification, characterization and validation of novel human drug targets for drug discovery continues to grow; this journal is essential reading for all pharmaceutical scientists involved in drug discovery and development. [1]
2024
Potential Target of CDK6 Signaling Pathway for Cancer Treatment.
R Basnet , OB Amissah , B Bahadur Basner , ... , Z Li
Current Drug Targets , 2024
Editorial Retractions, Expressions of Concern and External Notices
Retracted: Meet the Editorial Board Member.
Current Drug Targets2022 - VOLUME 23, ISSUE 1 p 1.
1 0
Notice not available.
Withdrawal Notice: TP53 Targetome: A Database of Novel Breast Cancer Biomarkers
Current Drug Targets2021 - VOLUME 22
0 0
Notice not available.
MM Rizwee , M Abidi , S Habib , ... , M Uddin
Current Drug Targets2021 - VOLUME 22
1 0
Notice not available.